| Year |
Citation |
Score |
| 2024 |
Bommaraju S, Dhokne MD, Arun EV, Srinivasan K, Sharma SS, Datusalia AK. An insight into crosstalk among multiple signalling pathways contributing to the pathophysiology of PTSD and depressive disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 131: 110943. PMID 38228244 DOI: 10.1016/j.pnpbp.2024.110943 |
0.441 |
|
| 2022 |
Sala N, Paoli C, Bonifacino T, Mingardi J, Schiavon E, La Via L, Milanese M, Tornese P, Datusalia AK, Rosa J, Facchinetti R, Frumento G, Carini G, Salerno Scarzella F, Scuderi C, et al. Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex. Frontiers in Pharmacology. 13: 759626. PMID 35370690 DOI: 10.3389/fphar.2022.759626 |
0.501 |
|
| 2021 |
Kaundal RK, Datusalia AK, Sharma SS. Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease. Pharmacological Research. 175: 106018. PMID 34863823 DOI: 10.1016/j.phrs.2021.106018 |
0.407 |
|
| 2019 |
Khatik GL, Datusalia AK, Vyas M. Current Pharmaceutical Interventions and Drug Design in the Management of Diabetes and Diabetic Complications. Current Pharmaceutical Design. 25: 2509. PMID 31589109 DOI: 10.2174/138161282523190913113841 |
0.392 |
|
| 2018 |
Datusalia AK, Agarwal P, Singh JN, Sharma SS. Hyper-insulinemia increases the glutamate-excitotoxicity in cortical neurons: A mechanistic study. European Journal of Pharmacology. 833: 524-530. PMID 30017861 DOI: 10.1016/J.Ejphar.2018.07.001 |
0.507 |
|
| 2016 |
Khare P, Datusalia AK, Sharma SS. Parthenolide, an NF-κB Inhibitor Ameliorates Diabetes-Induced Behavioural Deficit, Neurotransmitter Imbalance and Neuroinflammation in Type 2 Diabetes Rat Model. Neuromolecular Medicine. PMID 27553015 DOI: 10.1007/S12017-016-8434-6 |
0.624 |
|
| 2016 |
Jawale A, Datusalia AK, Bishnoi M, Sharma SS. Reversal of diabetes-induced behavioral and neurochemical deficits by cinnamaldehyde. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 23: 923-30. PMID 27387400 DOI: 10.1016/J.Phymed.2016.04.008 |
0.601 |
|
| 2016 |
Bajaj P, Tripathy RK, Aggarwal G, Datusalia AK, Sharma SS, Pande AH. Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning. Applied Biochemistry and Biotechnology. PMID 27131877 DOI: 10.1007/S12010-016-2091-Y |
0.468 |
|
| 2016 |
Datusalia AK, Sharma SS. Inhibition of GSK-3beta signalling improves cognitive deficits and glutamate-excitotoxicity in diabetes through transcription regulation of CREB European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31101-4 |
0.567 |
|
| 2015 |
Datusalia AK, Sharma SS. NF-κB Inhibition Resolves Cognitive Deficits in Experimental Type 2 Diabetes Mellitus through CREB and Glutamate/GABA Neurotransmitters Pathway. Current Neurovascular Research. PMID 26517200 DOI: 10.2174/1567202612666151030104810 |
0.603 |
|
| 2014 |
Jangra A, Datusalia AK, Sharma SS. Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-Isoquinolinediol a poly(ADP-ribose) polymerase inhibitor. Neurological Research. 36: 619-26. PMID 24620961 DOI: 10.1179/1743132813Y.0000000301 |
0.584 |
|
| 2014 |
Datusalia AK, Sharma SS. Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation. Molecular Neurobiology. 50: 390-405. PMID 24420785 DOI: 10.1007/S12035-014-8632-X |
0.602 |
|
| 2013 |
Jangra A, Datusalia AK, Khandwe S, Sharma SS. Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: implication of oxidative stress-PARP pathway. Pharmacology, Biochemistry, and Behavior. 114: 43-51. PMID 24201044 DOI: 10.1016/J.Pbb.2013.10.021 |
0.615 |
|
| Show low-probability matches. |